Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orgenesis Inc (OTCQB:ORGS)

0.36
Delayed Data
As of 3:21pm ET
 -0.04 / -10.00%
Today’s Change
0.30
Today|||52-Week Range
0.75
-37.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$39.4M

Company Description

Orgenesis, Inc. engages in the development of technology for the treatment of diabetes. It deals with the combination of cell-based therapy and regenerative medicine into clinical development. The company was founded on June 5, 2008 and is headquartered in White Plains, NY.

Contact Information

Orgenesis, Inc.
21 Sparrow Circle
White Plains New York 10605
P:(480) 659-6404
Investor Relations:

Employees

Shareholders

Individual stakeholders27.43%
Mutual fund holders--
Other institutional--

Top Executives

Vered CaplanChairman, President & Chief Executive Officer
Neil ReithingerChief Financial Officer, Secretary & Treasurer
Sarah FerberChief Scientific Officer